VOLUNTEER FOR RESEARCH
CBD for Bipolar Disorder
This project is an FDA-approved clinical trial of a hemp-derived, high-CBD sublingual product for the treatment of anxiety and depression in individuals with bipolar disorder.
Participants are assessed at 5 visits over the course of 4 weeks.
The primary outcome measures of the study are clinical state measures related to anxiety and depression. Additionally, participants will complete measures related to quality of life, sleep, and activity levels, and cognitive testing.
Visit https://clinicaltrials.gov/ct2/show/NCT05457465 for more info
Individuals with bipolar disorder who are interested in using a hemp-derived high CBD product for the treatment of anxiety and depression-related symptoms may be eligible.
We are currently recruiting individuals for the open-label phase (all participants would receive active treatment).